Adverse reactions or quality problems experienced with the use of this product may be reported to FDA’s MedWatch Adverse Event Reporting program either on line, by regular mail, or by.
The recall includes the following lots of this product:
This voluntary recall is being made with the knowledge of the U.S. Food and Drug Administration.
Endo is notifying all customers who may have received affected product and arranging for the return of any affected product.
FDA does not endorse either the product or the company. FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties.
Protecting and Promoting Your Health.
No injuries have been reported to date.
RSS Feed for FDA Recalls Information Photo: Product Labels.
This content has not been altered or updated since it was archived. The content on this page is provided for reference purposes only.
Lot numbers can be found on the side of the manufacturer’s bottle. These lots were distributed between April 19, 2011 and May 10, 2011 directly to wholesalers who are located in the following states: AL, AZ, CA, CO, NY, OH, ND, PR, IL, KY, NH, NJ, LA, NC, MO, PA, FL and TN. These wholesalers may further distribute to other retailers and wholesalers nationwide.
FOR IMMEDIATE RELEASE - June 24, 2011 - Endo Pharmaceuticals today issued a voluntary nationwide consumer level recall of Endocet (oxycodone/acetaminophen, USP) Tablets, 10 mg/325 mg 100 count bottles, NDC, Lot # 402415NV and #402426NV. One bottle from each lot of Endocet (oxycodone/acetaminophen, USP) Tablets, 10 mg/325 mg, Lot # 402415NV and # 402426NV, NDC, 100 count bottles, was found to contain some Endocet 10 mg/650 mg Tablets, which are identifiable by their larger size, and different shape and markings. Currently, no other bottles from the subject lots or any other lots have been found to erroneously contain Endocet 10 mg/650 mg Tablets.
Recalled Product Photos Are Also Available on FDA's Flickr Photostream.
About Endo Pharmaceuticals. Reports of adverse reactions or quality problems can also be reported to Endo Pharmaceuticals at.
Contact: Consumer: Media: Kevin Wiggins.
Consumers who have the affected product should stop using the product and contact Endo’s agent Stericycle at for return of the product. If consumers have any questions as to whether they possess the affected product, please call the number listed above.
The phones will be staffed by Stericycle. Consumers with questions may contact Endo’s agent Stericycle at during the hours of 8AM – 8PM EST Monday through Friday and 8AM – 5PM EST Saturday and Sunday.
Unintentional administration of tablets with increased acetaminophen content may result in liver toxicity, especially in patients on other acetaminophen containing medications, patients with liver dysfunction, or people who consume more than 3 alcoholic beverages a day. The product label warns consumers that acetaminophen overdosage can potentially cause severe liver damage. Because the recalled bottles may contain incorrect tablets that have a higher dosage of acetaminophen, consumers may take more than the intended acetaminophen dose.
For more information about Endo Pharmaceuticals, and its wholly owned subsidiaries American Medical Systems, Inc., HealthTronics, Inc. Endo is redefining its position in the healthcare marketplace by anticipating and embracing the evolution of health decisions based on the need for high-quality and cost-effective care. and Qualitest Pharmaceuticals, please visit http://www.endo.com/. We aim to be the premier partner to healthcare professionals and payment providers, delivering an innovative suite of complementary diagnostics, drugs, devices and clinical data to meet the needs of patients in areas such as pain, urology, oncology and endocrinology. Endo Pharmaceuticals is a U.S.-based, specialty healthcare solutions company, focused on high-value branded products and specialty generics. ###.
Page Last Updated: 02/13/2014 Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Endocet (oxycodone/acetaminophen, USP) 10 mg/325 mg tablets are 0.6 inches in length, 0.27 inches in width and yellow capsule-shaped tablets, marked “E712” on one side and “10/325” on the other. By contrast, Endocet (oxycodone/acetaminophen, USP) 10 mg/650 mg tablets are larger (0.7 inches in length, 0.4 inches in width) and yellow oval-shaped tablets, marked “E797” on one side and “10”on the other.Does oxycodone immediate release have acetaminophen